NUR 114 - Cellular Regulation (Colon Cancer) Exam IV

Question 1

helps with local cancer and is sometimes utilized as a palliative treatment. there are two types external and internal.

Answer 1

radiation therapy

Question 2

• avoid too much sunlight (photo-sensitivity)
• don’t remove radiation markings
• fatigue (primary symptom) can last for up to 6 months after treatment
• no lotion or creams on the treatment site
• do not scrub or rub treatment site (pat dry)
• taste buds can change.

Answer 2

nursing considerations for radiation therapy

Question 3

most common combination drug to treat cancer. classified as an metabolite agent, and messes with both RNA and DNA, attacks normal cells as well.

Answer 3

5 - Fluroracil (5 - FU)

Question 4

first sign of toxicity in response to this drug is stomatits. must assess the mucous membranes. then ther is : hepatoxicity (monitor liver function, bruising, and signs of jaundice). neurotoxicity ( assess LOC, mental status and signs of confusion). bone marrow toxicity (prone to falls, infection and bleeding) can also cause cerebellar changes (watch for changes in balance).
- this drug is given along with Leucovorin as a rescue drug to counter the toxicity effects of _____.

Answer 4

toxicity risk associated with the use of 5 - FU

Question 5

a natural chemotherapy agent that kills off the malignant cells that replicate very quickly.

• s/e: dizziness, headache, insomnia, weakness, nausea, and vomiting.
• a/e: bad diarrhea (happens within the first 24 hours of treatment). pulmonary toxicity (cough, fever, SOB), anemia, and neutropenia

Answer 5

Irintoecan (Topoismerate inhibitor)

Question 6

helps with the prevention of blood flow to the cancer. primarily given for metastatic colon cancer.
- monitor: signs of alopecia, thromboembolic disorders, gastric perforation, and heart failure.

Answer 6

Bevacizumb

Question 7

a monochromal antibody that means that it is a targeted chemotherapy agent. known to have severe infusion reactions. ( rash, respiratory issues, etc)

Answer 7

Cetuximab

Question 8

chemotherapy that is a combination of 5 - FU, Leucovorin, and Oxalliplatin. w/ Oxalliplatin there are concerns with peripheral neuropathy. With the medication there has to be a limit on the amount of medications given to the patient. The drug also has bone marrow suppressive agents to it.

Answer 8

Folfox